TIZANIDINE HYDROCHLORIDE

TIZANIDINE HYDROCHLORIDE was reported 18291 times

TIZANIDINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOFASCIAL PAIN SYNDROME 22 0.0309
1 LUMBAR RADICULOPATHY 29 0.0250
2 CERVICAL RADICULOPATHY 17 0.0238
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23 0.0217
4 INFUSION SITE DISCHARGE 33 0.0188
5 INFUSION SITE BRUISING 32 0.0148
6 PRE-EXISTING CONDITION IMPROVED 86 0.0138
7 NEUROGENIC BLADDER 29 0.0137
8 OBSTRUCTIVE SLEEP APNOEA SYNDROME 20 0.0137
9 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 25 0.0133
10 ESSENTIAL HYPERTENSION 23 0.0126
11 COMPLEX REGIONAL PAIN SYNDROME 18 0.0122
12 PRODUCT ADMINISTRATION INTERRUPTED 95 0.0121
13 INFUSION SITE PRURITUS 36 0.0114
14 HYPERPARATHYROIDISM SECONDARY 27 0.0108
15 PARAPLEGIA 31 0.0107
16 HAEMORRHAGIC DIATHESIS 38 0.0107
17 NEPHROGENIC ANAEMIA 49 0.0106
18 MUSCLE SPASTICITY 129 0.0105
19 DRUG SCREEN NEGATIVE 18 0.0102
20 BLADDER SPASM 19 0.0101
21 CERVICAL SPINAL STENOSIS 17 0.0099
22 PNEUMONIA ASPIRATION 240 0.0096
23 INFUSION SITE HAEMORRHAGE 31 0.0094
24 DYSPHORIA 47 0.0093
25 ARTHRITIS INFECTIVE 43 0.0093
26 INTERVERTEBRAL DISC DEGENERATION 83 0.0090
27 CARTILAGE INJURY 22 0.0089
28 SPINAL FUSION SURGERY 36 0.0089
29 CYSTITIS INTERSTITIAL 14 0.0087
30 LUMBAR SPINAL STENOSIS 25 0.0085
31 INTERVERTEBRAL DISC DISORDER 36 0.0084
32 SPINAL OSTEOARTHRITIS 73 0.0083
33 INFUSION SITE SWELLING 52 0.0083
34 ACUTE SINUSITIS 14 0.0081
35 NARCOLEPSY 15 0.0079
36 MULTIPLE ALLERGIES 62 0.0079
37 ANXIETY DISORDER 26 0.0078
38 FACIAL BONES FRACTURE 28 0.0078
39 DEVICE INFUSION ISSUE 19 0.0077
40 FIBULA FRACTURE 22 0.0076
41 URINARY TRACT INFECTION BACTERIAL 19 0.0075
42 POST-TRAUMATIC STRESS DISORDER 50 0.0075
43 INTERVERTEBRAL DISC PROTRUSION 162 0.0074
44 PATELLA FRACTURE 17 0.0073
45 IMPAIRED GASTRIC EMPTYING 99 0.0073
46 APPETITE DISORDER 48 0.0072
47 RADICULOPATHY 19 0.0072
48 SEASONAL ALLERGY 101 0.0071
49 DRUG TOLERANCE 36 0.0071
50 DIABETIC NEUROPATHY 35 0.0071
51 SKIN WARM 41 0.0070
52 NECK SURGERY 16 0.0069
53 FIBROMYALGIA 167 0.0069
54 SLEEP APNOEA SYNDROME 127 0.0066
55 INFUSION SITE ERYTHEMA 55 0.0065
56 MULTIPLE SCLEROSIS 311 0.0065
57 TENDERNESS 66 0.0063
58 INFUSION SITE PAIN 80 0.0062
59 RHINITIS ALLERGIC 27 0.0061
60 BREAKTHROUGH PAIN 14 0.0060
61 ANKLE FRACTURE 92 0.0059
62 MULTIPLE SCLEROSIS RELAPSE 406 0.0059
63 VITAMIN D DEFICIENCY 57 0.0058
64 NECK INJURY 17 0.0058
65 METABOLIC ENCEPHALOPATHY 17 0.0057
66 DECUBITUS ULCER 46 0.0056
67 MAJOR DEPRESSION 41 0.0056
68 DECREASED INTEREST 33 0.0056
69 CHRONIC SINUSITIS 21 0.0056
70 SNORING 21 0.0055
71 GASTROOESOPHAGEAL REFLUX DISEASE 446 0.0055
72 BACK DISORDER 89 0.0055
73 PERONEAL NERVE PALSY 31 0.0055
74 ENURESIS 22 0.0054
75 LIGAMENT RUPTURE 24 0.0054
76 INADEQUATE ANALGESIA 46 0.0054
77 RESPIRATORY RATE DECREASED 17 0.0054
78 PERSONALITY DISORDER 14 0.0053
79 SCOLIOSIS 33 0.0053
80 BRONCHITIS CHRONIC 13 0.0053
81 CONCUSSION 41 0.0053
82 COMA 252 0.0053
83 OESOPHAGEAL STENOSIS 15 0.0053
84 TRIGEMINAL NEURALGIA 21 0.0052
85 NERVE COMPRESSION 48 0.0052
86 NEURALGIA 126 0.0052
87 LIGAMENT SPRAIN 51 0.0052
88 THINKING ABNORMAL 95 0.0051
89 DERMATITIS CONTACT 58 0.0051
90 SPINAL COLUMN STENOSIS 24 0.0051
91 GLUCOSE TOLERANCE IMPAIRED 30 0.0051
92 NON-CARDIAC CHEST PAIN 16 0.0051
93 INFUSION SITE REACTION 15 0.0050
94 OBSTRUCTION 20 0.0050
95 EAR PAIN 97 0.0050
96 NECK PAIN 277 0.0050
97 END STAGE RENAL DISEASE 89 0.0049
98 AREFLEXIA 13 0.0049
99 HYPERLIPIDAEMIA 58 0.0048
100 HYPERTONIC BLADDER 14 0.0048
101 RESTLESS LEGS SYNDROME 88 0.0048
102 BLADDER DISORDER 48 0.0048
103 BACK INJURY 52 0.0048
104 AUTOIMMUNE THYROIDITIS 18 0.0048
105 SPINAL DISORDER 45 0.0047
106 FOOT FRACTURE 90 0.0047
107 SOMNAMBULISM 31 0.0047
108 PARANASAL SINUS HYPERSECRETION 18 0.0047
109 INSURANCE ISSUE 72 0.0047
110 INCORRECT DRUG ADMINISTRATION RATE 20 0.0047
111 INITIAL INSOMNIA 48 0.0047
112 HAND FRACTURE 33 0.0047
113 TEMPERATURE INTOLERANCE 48 0.0046
114 DIFFICULTY IN WALKING 16 0.0046
115 SPINAL OPERATION 57 0.0046
116 ROTATOR CUFF SYNDROME 59 0.0046
117 MIGRAINE 436 0.0046
118 PHOTOPHOBIA 85 0.0045
119 LYME DISEASE 15 0.0045
120 CARPAL TUNNEL SYNDROME 63 0.0045
121 BURSITIS 54 0.0044
122 VITAMIN B12 DEFICIENCY 18 0.0044
123 OSTEOARTHRITIS 184 0.0043
124 MUSCLE TIGHTNESS 70 0.0043
125 FORMICATION 30 0.0043
126 SINUS DISORDER 85 0.0043
127 URINARY INCONTINENCE 127 0.0043
128 FOOT OPERATION 21 0.0042
129 INTRACRANIAL ANEURYSM 17 0.0042
130 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 14 0.0042
131 TOOTH ABSCESS 43 0.0042
132 FIBRIN D DIMER INCREASED 15 0.0042
133 URINARY TRACT DISORDER 19 0.0042
134 JOINT EFFUSION 29 0.0042
135 HAEMOGLOBIN INCREASED 19 0.0042
136 FAECAL INCONTINENCE 20 0.0042
137 HYSTERECTOMY 36 0.0042
138 CYSTITIS 132 0.0041
139 SPONDYLITIS 15 0.0041
140 SENSORY LOSS 33 0.0041
141 VITAMIN D DECREASED 35 0.0041
142 CHRONIC KIDNEY DISEASE 311 0.0041
143 DRUG ABUSER 25 0.0041
144 BLOOD MAGNESIUM DECREASED 35 0.0041
145 EXOSTOSIS 37 0.0040
146 LYMPHOEDEMA 28 0.0040
147 ATELECTASIS 39 0.0040
148 MULTIPLE DRUG OVERDOSE 20 0.0040
149 SKIN ABRASION 19 0.0040
150 HYPERREFLEXIA 14 0.0040
151 SINUSITIS 411 0.0040
152 KIDNEY INFECTION 78 0.0040
153 PARANASAL SINUS DISCOMFORT 15 0.0040
154 SKIN LACERATION 43 0.0040
155 ARTHROPOD BITE 29 0.0039
156 OVERWEIGHT 21 0.0039
157 THYROID MASS 15 0.0039
158 BRONCHITIS 288 0.0039
159 DYSARTHRIA 146 0.0039
160 HYPERVOLAEMIA 19 0.0038
161 BLOOD POTASSIUM DECREASED 114 0.0038
162 MICTURITION URGENCY 43 0.0038
163 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
164 SCIATICA 60 0.0038
165 WEIGHT FLUCTUATION 39 0.0037
166 SINUS BRADYCARDIA 36 0.0037
167 CENTRAL NERVOUS SYSTEM LESION 51 0.0037
168 HIATUS HERNIA 48 0.0037
169 DENTAL CARIES 41 0.0037
170 URINARY TRACT INFECTION 632 0.0037
171 INFUSION SITE EXTRAVASATION 23 0.0037
172 LOSS OF CONTROL OF LEGS 14 0.0037
173 POST PROCEDURAL INFECTION 30 0.0037
174 PERIPHERAL VASCULAR DISORDER 19 0.0037
175 NASAL DRYNESS 23 0.0037
176 DRUG SCREEN POSITIVE 29 0.0037
177 THERMAL BURN 26 0.0037
178 GASTROENTERITIS VIRAL 66 0.0037
179 CLAVICLE FRACTURE 14 0.0037
180 PANCREATIC DISORDER 18 0.0036
181 WALKING AID USER 24 0.0036
182 INCONTINENCE 38 0.0036
183 OBESITY 57 0.0036
184 ORAL PAIN 80 0.0036
185 HALLUCINATIONS, MIXED 15 0.0036
186 ROAD TRAFFIC ACCIDENT 149 0.0036
187 FLANK PAIN 33 0.0035
188 DIVERTICULUM 25 0.0035
189 JOINT INJURY 75 0.0035
190 OVARIAN CYST 35 0.0035
191 SPINAL PAIN 41 0.0035
192 BIPOLAR DISORDER 38 0.0035
193 UPPER RESPIRATORY TRACT INFECTION 161 0.0035
194 HYPOAESTHESIA 520 0.0035
195 PRODUCT DISTRIBUTION ISSUE 32 0.0034
196 DIVERTICULUM INTESTINAL 15 0.0034
197 MENTAL STATUS CHANGES 95 0.0034
198 DYSPHEMIA 15 0.0034
199 NERVE INJURY 38 0.0034
200 MENISCUS INJURY 21 0.0034
201 DEPRESSION 777 0.0034
202 STREPTOCOCCAL INFECTION 19 0.0034
203 TIBIA FRACTURE 16 0.0034
204 INCOHERENT 22 0.0034
205 SPINAL STENOSIS 14 0.0034
206 ENERGY INCREASED 20 0.0034
207 MUSCLE SPASMS 621 0.0034
208 LOWER LIMB FRACTURE 65 0.0034
209 MIDDLE INSOMNIA 63 0.0034
210 BODY HEIGHT DECREASED 36 0.0034
211 SINUS HEADACHE 20 0.0034
212 UROSEPSIS 31 0.0034
213 MUSCLE STRAIN 29 0.0033
214 DIPLOPIA 87 0.0033
215 BALANCE DISORDER 289 0.0033
216 STRESS FRACTURE 18 0.0033
217 SOMNOLENCE 668 0.0033
218 JOINT DISLOCATION 35 0.0033
219 FOREIGN BODY SENSATION IN EYES 21 0.0033
220 UTERINE LEIOMYOMA 24 0.0033
221 EAR INFECTION 87 0.0033
222 HEAD INJURY 103 0.0033
223 SYNOVIAL CYST 15 0.0032
224 SEDATION 85 0.0032
225 HYPOKINESIA 47 0.0032
226 FEELING DRUNK 24 0.0032
227 RHINITIS 26 0.0032
228 PANIC ATTACK 117 0.0032
229 SKIN INFECTION 36 0.0032
230 LIMB INJURY 87 0.0032
231 INFLUENZA LIKE ILLNESS 263 0.0032
232 BACK PAIN 741 0.0032
233 UPPER-AIRWAY COUGH SYNDROME 26 0.0032
234 FALL 1047 0.0031
235 CHOLECYSTITIS CHRONIC 21 0.0031
236 GAIT DISTURBANCE 600 0.0031
237 OBSESSIVE-COMPULSIVE DISORDER 25 0.0031
238 HEPATIC STEATOSIS 58 0.0031
239 TOOTH INFECTION 41 0.0031
240 MUSCULOSKELETAL CHEST PAIN 48 0.0031
241 OSTEOPENIA 47 0.0031
242 VASCULAR DEVICE INFECTION 14 0.0031
243 LACERATION 29 0.0031
244 ACTIVITIES OF DAILY LIVING IMPAIRED 61 0.0031
245 TENDON RUPTURE 38 0.0031
246 HYPERSOMNIA 88 0.0031
247 ABDOMINAL HERNIA 14 0.0031
248 CONVULSION 175 0.0031
249 SURGERY 179 0.0031
250 INCREASED TENDENCY TO BRUISE 28 0.0030
251 MOTOR DYSFUNCTION 31 0.0030
252 DYSGRAPHIA 20 0.0030
253 SINUS CONGESTION 41 0.0030
254 TRICUSPID VALVE INCOMPETENCE 24 0.0030
255 ABDOMINAL TENDERNESS 15 0.0030
256 POST PROCEDURAL COMPLICATION 58 0.0030
257 DYSSTASIA 88 0.0030
258 COORDINATION ABNORMAL 42 0.0030
259 NEPHROLITHIASIS 138 0.0030
260 WRIST FRACTURE 36 0.0030
261 PRODUCT DOSE OMISSION IN ERROR 85 0.0030
262 TOOTH FRACTURE 33 0.0030
263 ORTHOSTATIC HYPOTENSION 52 0.0030
264 WITHDRAWAL SYNDROME 125 0.0030
265 CANDIDA INFECTION 50 0.0030
266 RESPIRATORY TRACT CONGESTION 47 0.0030
267 PELVIC FRACTURE 23 0.0030
268 HEMIPARESIS 50 0.0029
269 HERPES VIRUS INFECTION 17 0.0029
270 CONTUSION 284 0.0029
271 MEMORY IMPAIRMENT 404 0.0029
272 SOCIAL AVOIDANT BEHAVIOUR 17 0.0029
273 CATHETERISATION CARDIAC 13 0.0029
274 EYE PAIN 165 0.0029
275 ABASIA 72 0.0029
276 FACIAL PAIN 26 0.0029
277 ILLNESS 300 0.0029
278 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 24 0.0029
279 HYPOVOLAEMIA 17 0.0029
280 PARANOIA 50 0.0029
281 POOR VENOUS ACCESS 30 0.0029
282 BLOOD PRESSURE ABNORMAL 57 0.0029
283 ATAXIA 34 0.0029
284 PHARYNGITIS STREPTOCOCCAL 31 0.0029
285 MALNUTRITION 32 0.0029
286 SNEEZING 64 0.0029
287 FUNGAL INFECTION 95 0.0028
288 CARDIOMEGALY 35 0.0028
289 RESPIRATORY TRACT INFECTION 74 0.0028
290 LOSS OF CONSCIOUSNESS 362 0.0028
291 PHARYNGOLARYNGEAL PAIN 15 0.0028
292 PHARYNGITIS 35 0.0028
293 HALLUCINATION 211 0.0028
294 MUSCULOSKELETAL STIFFNESS 245 0.0028
295 HYPERTONIA 16 0.0028
296 CORONARY ARTERY STENOSIS 14 0.0028
297 ANAL INCONTINENCE 25 0.0028
298 GASTRITIS 73 0.0028
299 MUSCULAR WEAKNESS 314 0.0028
300 WRONG TECHNIQUE IN DRUG USAGE PROCESS 100 0.0027
301 SCRATCH 29 0.0027
302 OSTEOPOROSIS 113 0.0027
303 LIMB DISCOMFORT 85 0.0027
304 SLUGGISHNESS 28 0.0027
305 ANHEDONIA 72 0.0027
306 BEDRIDDEN 36 0.0027
307 MUSCLE DISORDER 22 0.0027
308 ABNORMAL DREAMS 75 0.0027
309 BENIGN PROSTATIC HYPERPLASIA 14 0.0027
310 OEDEMA 147 0.0027
311 THERAPEUTIC RESPONSE UNEXPECTED 121 0.0027
312 SCAR 46 0.0027
313 MALABSORPTION 14 0.0027
314 BRAIN FOG 42 0.0027
315 SENSORY DISTURBANCE 43 0.0027
316 AMNESIA 173 0.0027
317 CARDIAC MURMUR 23 0.0027
318 IMMUNE SYSTEM DISORDER 35 0.0027
319 HEART RATE DECREASED 93 0.0026
320 OPTIC NEURITIS 24 0.0026
321 IMPAIRED DRIVING ABILITY 30 0.0026
322 BLOOD PRESSURE DECREASED 175 0.0026
323 RETCHING 56 0.0026
324 HERPES SIMPLEX 17 0.0026
325 VISUAL DISTURBANCE 15 0.0026
326 KNEE ARTHROPLASTY 55 0.0026
327 LYMPHOCYTE COUNT DECREASED 46 0.0026
328 CELLULITIS 131 0.0026
329 TRANSIENT ISCHAEMIC ATTACK 87 0.0026
330 MUSCULOSKELETAL PAIN 135 0.0026
331 ARTHRITIS 202 0.0026
332 HYPERAESTHESIA 21 0.0026
333 VIRAL INFECTION 85 0.0026
334 ELECTROCARDIOGRAM ABNORMAL 20 0.0025
335 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 133 0.0025
336 FLUSHING 259 0.0025
337 STAPHYLOCOCCAL INFECTION 84 0.0025
338 HIP ARTHROPLASTY 39 0.0025
339 DRY MOUTH 206 0.0025
340 CRYING 92 0.0025
341 RIB FRACTURE 52 0.0025
342 RENAL CYST 20 0.0025
343 BLOOD CALCIUM INCREASED 22 0.0025
344 EYE MOVEMENT DISORDER 17 0.0025
345 TREMOR 411 0.0025
346 CHILLS 289 0.0025
347 GALLBLADDER DISORDER 44 0.0025
348 COGNITIVE DISORDER 115 0.0025
349 POOR QUALITY SLEEP 53 0.0025
350 ANXIETY 699 0.0025
351 CHOLECYSTECTOMY 28 0.0024
352 DRUG WITHDRAWAL SYNDROME 215 0.0024
353 RENAL TUBULAR NECROSIS 24 0.0024
354 BLOOD IRON DECREASED 29 0.0024
355 ECONOMIC PROBLEM 37 0.0024
356 SMALL INTESTINAL OBSTRUCTION 30 0.0024
357 INFLUENZA 271 0.0024
358 ACCIDENT 29 0.0024
359 BURNING SENSATION 170 0.0024
360 CYST 30 0.0024
361 INSOMNIA 642 0.0024
362 HAEMORRHOIDS 47 0.0024
363 PAIN 1479 0.0024
364 THYROID DISORDER 37 0.0024
365 ASTHMA 271 0.0024
366 HALLUCINATION, AUDITORY 38 0.0024
367 NIGHT SWEATS 77 0.0024
368 SPEECH DISORDER 125 0.0024
369 IRON DEFICIENCY ANAEMIA 22 0.0024
370 DISABILITY 47 0.0024
371 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 114 0.0024
372 PERSONALITY CHANGE 22 0.0024
373 COVID-19 414 0.0024
374 LOCALISED INFECTION 57 0.0024
375 PHARYNGEAL SWELLING 23 0.0023
376 BOWEL MOVEMENT IRREGULARITY 18 0.0023
377 PULMONARY MASS 35 0.0023
378 COMPLICATION ASSOCIATED WITH DEVICE 34 0.0023
379 DYSPHAGIA 222 0.0023
380 SKIN DISORDER 78 0.0023
381 BLOOD SODIUM DECREASED 44 0.0023
382 PRESCRIBED OVERDOSE 45 0.0023
383 SPUTUM DISCOLOURED 22 0.0023
384 BLOOD CHOLESTEROL INCREASED 108 0.0023
385 BLOOD CALCIUM DECREASED 26 0.0023
386 LARGE INTESTINE POLYP 16 0.0023
387 ANGER 78 0.0023
388 GAIT INABILITY 77 0.0023
389 HYPOPHOSPHATAEMIA 17 0.0023
390 BLOOD PRESSURE INCREASED 351 0.0023
391 LOCAL SWELLING 40 0.0023
392 CHEST PAIN 424 0.0023
393 HEADACHE 1431 0.0023
394 INTESTINAL OBSTRUCTION 86 0.0023
395 INTENTIONAL DOSE OMISSION 65 0.0023
396 MOVEMENT DISORDER 73 0.0023
397 COLD SWEAT 40 0.0023
398 MUSCULOSKELETAL DISCOMFORT 39 0.0023
399 CONSTIPATION 494 0.0023
400 NASAL CONGESTION 133 0.0023
401 DYSURIA 83 0.0023
402 PARAESTHESIA 353 0.0022
403 DEHYDRATION 299 0.0022
404 HEPATOMEGALY 22 0.0022
405 SEROTONIN SYNDROME 43 0.0022
406 KNEE OPERATION 22 0.0022
407 HYPERTENSION 473 0.0022
408 COMPLETED SUICIDE 186 0.0022
409 HYPERHIDROSIS 287 0.0022
410 TYPE 2 DIABETES MELLITUS 75 0.0022
411 SKIN HAEMORRHAGE 33 0.0022
412 HUNGER 31 0.0022
413 NOCTURIA 27 0.0022
414 COLITIS ISCHAEMIC 15 0.0022
415 HYPOTHYROIDISM 71 0.0022
416 POSTOPERATIVE WOUND INFECTION 15 0.0022
417 DISORIENTATION 88 0.0022
418 SUICIDAL IDEATION 202 0.0022
419 DISTURBANCE IN ATTENTION 119 0.0022
420 HYPOTONIA 22 0.0022
421 FOOD ALLERGY 17 0.0022
422 PAIN IN EXTREMITY 646 0.0022
423 ASPIRATION 24 0.0022
424 BLISTER 123 0.0022
425 LETHARGY 126 0.0022
426 DYSKINESIA 89 0.0022
427 RESPIRATORY SYNCYTIAL VIRUS INFECTION 19 0.0022
428 GALACTORRHOEA 14 0.0022
429 PNEUMONIA BACTERIAL 20 0.0022
430 HYPERCHOLESTEROLAEMIA 21 0.0022
431 TOOTH EXTRACTION 27 0.0022
432 MUSCLE TWITCHING 50 0.0022
433 CARDIAC FLUTTER 14 0.0022
434 GROIN PAIN 19 0.0022
435 ANGINA UNSTABLE 14 0.0022
436 APHONIA 30 0.0021
437 EUPHORIC MOOD 22 0.0021
438 IRRITABLE BOWEL SYNDROME 46 0.0021
439 EAR DISCOMFORT 22 0.0021
440 MOBILITY DECREASED 154 0.0021
441 POLYP 14 0.0021
442 OCULAR DISCOMFORT 24 0.0021
443 DECREASED ACTIVITY 23 0.0021
444 THIRST 38 0.0021
445 WHEEZING 126 0.0021
446 NEUROPATHY PERIPHERAL 202 0.0021
447 ARTHROPATHY 118 0.0021
448 GASTROINTESTINAL INFECTION 19 0.0021
449 INJECTION SITE URTICARIA 52 0.0021
450 APHASIA 64 0.0021
451 CORONARY ARTERY DISEASE 64 0.0021
452 POLLAKIURIA 88 0.0021
453 DRY EYE 105 0.0021
454 OSTEOMYELITIS 38 0.0021
455 PRODUCT DOSE OMISSION ISSUE 617 0.0021
456 WEIGHT DECREASED 585 0.0021
457 JOINT RANGE OF MOTION DECREASED 28 0.0021
458 ORAL DISCOMFORT 29 0.0021
459 BREAST MASS 14 0.0021
460 VERTIGO 127 0.0021
461 AFFECT LABILITY 20 0.0021
462 WOUND 58 0.0021
463 ULCER 33 0.0021
464 FEELING ABNORMAL 497 0.0021
465 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0021
466 ESCHERICHIA INFECTION 17 0.0021
467 DRY THROAT 21 0.0021
468 FLUID RETENTION 105 0.0021
469 VISION BLURRED 283 0.0021
470 UPPER LIMB FRACTURE 41 0.0021
471 RHINORRHOEA 133 0.0021
472 DIVERTICULITIS 57 0.0021
473 RENAL INJURY 61 0.0021
474 AUTOIMMUNE DISORDER 20 0.0020
475 NIGHTMARE 71 0.0020
476 THROMBOSIS 165 0.0020
477 RENAL FAILURE 272 0.0020
478 FEELING JITTERY 39 0.0020
479 ASTHENIA 768 0.0020
480 PERIPHERAL COLDNESS 28 0.0020
481 EYE INFECTION 23 0.0020
482 PSYCHIATRIC SYMPTOM 15 0.0020
483 DROOLING 14 0.0020
484 PARALYSIS 29 0.0020
485 DRUG EFFECT LESS THAN EXPECTED 30 0.0020
486 HYPOTENSION 406 0.0020
487 FEELING HOT 124 0.0020
488 HERPES ZOSTER 116 0.0020
489 PROCEDURAL PAIN 56 0.0020
490 PULMONARY THROMBOSIS 22 0.0020
491 HAEMATOCRIT DECREASED 40 0.0020
492 DEEP VEIN THROMBOSIS 131 0.0020
493 PHARYNGEAL OEDEMA 31 0.0020
494 UNRESPONSIVE TO STIMULI 52 0.0020
495 PAIN IN JAW 57 0.0020
496 WOUND INFECTION 22 0.0020
497 APPLICATION SITE VESICLES 13 0.0020
498 TENDONITIS 31 0.0020
499 GASTROINTESTINAL PAIN 22 0.0020
500 SLEEP DISORDER 141 0.0020
501 MUSCULOSKELETAL DISORDER 38 0.0020
502 SPINAL FRACTURE 40 0.0020
503 RESPIRATORY ARREST 55 0.0020
504 FATIGUE 1549 0.0020
505 TOOTHACHE 36 0.0020
506 FOOT DEFORMITY 22 0.0020
507 BACTERIAL INFECTION 37 0.0020
508 JOINT STIFFNESS 52 0.0020
509 ARTHRALGIA 824 0.0020
510 RENAL PAIN 21 0.0020
511 TOOTH DISORDER 44 0.0020
512 OROPHARYNGEAL PAIN 183 0.0020
513 FEELING COLD 55 0.0020
514 WEIGHT INCREASED 442 0.0020
515 MUSCLE ATROPHY 25 0.0020
516 VISUAL IMPAIRMENT 244 0.0020
517 CORONARY ARTERY OCCLUSION 27 0.0020
518 BODY TEMPERATURE INCREASED 40 0.0020
519 HEREDITARY ANGIOEDEMA 21 0.0020
520 PROCEDURAL COMPLICATION 15 0.0020
521 MYALGIA 332 0.0020
522 BONE PAIN 114 0.0019
523 ANOREXIA 25 0.0019
524 OXYGEN SATURATION DECREASED 109 0.0019
525 SCAB 22 0.0019
526 APNOEA 15 0.0019
527 PHARMACEUTICAL PRODUCT COMPLAINT 50 0.0019
528 LUNG INFILTRATION 17 0.0019
529 CHOLELITHIASIS 63 0.0019
530 GASTROENTERITIS 28 0.0019
531 DYSPNOEA EXERTIONAL 72 0.0019
532 ABNORMAL LOSS OF WEIGHT 13 0.0019
533 DIZZINESS 950 0.0019
534 ACUTE KIDNEY INJURY 291 0.0019
535 ORAL CANDIDIASIS 25 0.0019
536 PULMONARY CONGESTION 25 0.0019
537 PRURITUS GENERALISED 41 0.0019
538 HALLUCINATION, VISUAL 40 0.0019
539 PRESYNCOPE 46 0.0019
540 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
541 BRADYCARDIA 100 0.0019
542 PRODUCTIVE COUGH 90 0.0019
543 HOT FLUSH 142 0.0019
544 EMPHYSEMA 19 0.0019
545 SEIZURE 217 0.0019
546 EATING DISORDER 40 0.0019
547 HYPOXIA 66 0.0019
548 NAUSEA 1482 0.0019
549 ACUTE RESPIRATORY FAILURE 36 0.0019
550 HEART RATE INCREASED 185 0.0019
551 HEART RATE IRREGULAR 42 0.0019
552 MENTAL IMPAIRMENT 45 0.0019
553 PAROSMIA 14 0.0019
554 OEDEMA PERIPHERAL 226 0.0019
555 DYSPEPSIA 182 0.0018
556 DIABETES MELLITUS 141 0.0018
557 AORTIC ANEURYSM 14 0.0018
558 ABNORMAL FAECES 15 0.0018
559 EYE DISCHARGE 19 0.0018
560 TINNITUS 84 0.0018
561 EYE SWELLING 68 0.0018
562 IMPAIRED HEALING 60 0.0018
563 PNEUMONIA 590 0.0018
564 CONFUSIONAL STATE 294 0.0018
565 GRIP STRENGTH DECREASED 16 0.0018
566 IMMUNOSUPPRESSION 16 0.0018
567 IRRITABILITY 109 0.0018
568 COUGH 508 0.0018
569 INJECTION SITE IRRITATION 23 0.0018
570 GASTRIC DISORDER 62 0.0018
571 DRUG ADMINISTERED AT INAPPROPRIATE SITE 19 0.0018
572 MOOD ALTERED 49 0.0018
573 INJURY 126 0.0018
574 SYNCOPE 179 0.0018
575 ABDOMINAL DISTENSION 186 0.0018
576 AFFECTIVE DISORDER 14 0.0018
577 ABDOMINAL DISCOMFORT 298 0.0018
578 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
579 DEVICE FAILURE 27 0.0018
580 EYELID PTOSIS 18 0.0018
581 UNEVALUABLE EVENT 134 0.0018
582 MITRAL VALVE INCOMPETENCE 20 0.0018
583 FURUNCLE 14 0.0018
584 PERIPHERAL SWELLING 272 0.0018
585 PSYCHOTIC DISORDER 52 0.0018
586 CHEST DISCOMFORT 180 0.0018
587 DIZZINESS POSTURAL 17 0.0018
588 WHITE BLOOD CELL COUNT INCREASED 67 0.0017
589 DEPRESSED LEVEL OF CONSCIOUSNESS 69 0.0017
590 ABNORMAL BEHAVIOUR 69 0.0017
591 VENTRICULAR EXTRASYSTOLES 18 0.0017
592 HYPOKALAEMIA 80 0.0017
593 FRUSTRATION TOLERANCE DECREASED 14 0.0017
594 SKIN SWELLING 15 0.0017
595 LYMPHADENOPATHY 61 0.0017
596 LACRIMATION INCREASED 52 0.0017
597 QUALITY OF LIFE DECREASED 23 0.0017
598 INABILITY TO AFFORD MEDICATION 17 0.0017
599 POLYURIA 14 0.0017
600 MANIA 28 0.0017
601 THROAT TIGHTNESS 46 0.0017
602 MENTAL DISORDER 74 0.0017
603 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
604 COVID-19 PNEUMONIA 20 0.0017
605 SPINAL COMPRESSION FRACTURE 14 0.0017
606 DEPRESSED MOOD 89 0.0017
607 CHOLECYSTITIS 20 0.0017
608 FEEDING DISORDER 34 0.0017
609 VOMITING 788 0.0017
610 PALPITATIONS 196 0.0017
611 RHEUMATOID ARTHRITIS 190 0.0017
612 BLOOD UREA INCREASED 28 0.0017
613 NASOPHARYNGITIS 307 0.0017
614 CATARACT 99 0.0017
615 SYSTEMIC LUPUS ERYTHEMATOSUS 59 0.0017
616 DYSPHONIA 97 0.0017
617 PULMONARY EMBOLISM 157 0.0017
618 HYPOMAGNESAEMIA 23 0.0017
619 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 28 0.0016
620 BONE DISORDER 30 0.0016
621 BLOOD TRIGLYCERIDES INCREASED 29 0.0016
622 RESPIRATORY DEPRESSION 20 0.0016
623 GASTRIC ULCER 31 0.0016
624 BLOOD PRESSURE FLUCTUATION 39 0.0016
625 JOINT SWELLING 196 0.0016
626 INCREASED APPETITE 31 0.0016
627 GENERALISED OEDEMA 20 0.0016
628 SWELLING 151 0.0016
629 NERVOUSNESS 84 0.0016
630 AGITATION 118 0.0016
631 THROAT IRRITATION 72 0.0016
632 SKIN LESION 44 0.0016
633 HERNIA 31 0.0016
634 MOOD SWINGS 51 0.0016
635 THERAPY CESSATION 82 0.0016
636 SECRETION DISCHARGE 20 0.0016
637 BRAIN INJURY 16 0.0016
638 ARTERIOSCLEROSIS 15 0.0016
639 MUSCLE RIGIDITY 19 0.0016
640 DYSPNOEA 899 0.0016
641 HIP FRACTURE 51 0.0016
642 HAEMATOMA 41 0.0016
643 FLUID OVERLOAD 23 0.0016
644 BLOOD URINE PRESENT 30 0.0016
645 RENAL FAILURE ACUTE 67 0.0016
646 APATHY 23 0.0016
647 PSORIATIC ARTHROPATHY 64 0.0016
648 CONDITION AGGRAVATED 479 0.0016
649 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 27 0.0016
650 ANGINA PECTORIS 45 0.0016
651 CARDIAC FAILURE CONGESTIVE 126 0.0016
652 INJECTION SITE RASH 48 0.0016
653 SEPSIS 174 0.0016
654 DRUG EFFECT DECREASED 84 0.0016
655 OROPHARYNGEAL DISCOMFORT 14 0.0015
656 SINUS TACHYCARDIA 22 0.0015
657 ANAPHYLACTIC REACTION 85 0.0015
658 THERAPEUTIC RESPONSE SHORTENED 51 0.0015
659 RESPIRATORY DISORDER 46 0.0015
660 PULMONARY HYPERTENSION 32 0.0015
661 INFECTION 222 0.0015
662 VITREOUS FLOATERS 15 0.0015
663 EYE DISORDER 50 0.0015
664 ABDOMINAL PAIN UPPER 313 0.0015
665 LIVER FUNCTION TEST ABNORMAL 44 0.0015
666 INTENTIONAL PRODUCT USE ISSUE 132 0.0015
667 MASS 21 0.0015
668 PRURITUS 577 0.0015
669 NEPHROPATHY 14 0.0015
670 FLATULENCE 85 0.0015
671 TUBULOINTERSTITIAL NEPHRITIS 28 0.0015
672 RASH MACULAR 52 0.0015
673 ABDOMINAL PAIN 346 0.0015
674 HYPOPHAGIA 38 0.0015
675 LYMPHOPENIA 21 0.0015
676 SUICIDE ATTEMPT 90 0.0015
677 HEPATIC ENZYME INCREASED 101 0.0015
678 DRUG TOXICITY 20 0.0015
679 ENCEPHALOPATHY 36 0.0015
680 RENAL DISORDER 68 0.0015
681 NODULE 19 0.0015
682 PRODUCT DOSE OMISSION 95 0.0015
683 INJECTION SITE BRUISING 116 0.0015
684 FEAR 39 0.0014
685 RECTAL HAEMORRHAGE 62 0.0014
686 GASTROINTESTINAL DISORDER 129 0.0014
687 SKIN ULCER 37 0.0014
688 TACHYCARDIA 127 0.0014
689 DEVICE RELATED INFECTION 22 0.0014
690 DECREASED IMMUNE RESPONSIVENESS 14 0.0014
691 FEMUR FRACTURE 44 0.0014
692 HAEMATEMESIS 36 0.0014
693 SKIN DISCOLOURATION 65 0.0014
694 HEAD DISCOMFORT 25 0.0014
695 IMMUNODEFICIENCY 21 0.0014
696 URINARY RETENTION 47 0.0014
697 IMPAIRED WORK ABILITY 30 0.0014
698 SALIVARY HYPERSECRETION 14 0.0014
699 RED BLOOD CELL COUNT DECREASED 40 0.0014
700 PRODUCT USE COMPLAINT 22 0.0014
701 PALLOR 38 0.0014
702 VENTRICULAR TACHYCARDIA 23 0.0014
703 DYSTONIA 27 0.0014
704 DIARRHOEA 896 0.0014
705 APPLICATION SITE RASH 19 0.0014
706 LEUKOCYTOSIS 25 0.0014
707 INJECTION SITE HAEMATOMA 20 0.0014
708 MENORRHAGIA 27 0.0014
709 BLOOD ALKALINE PHOSPHATASE INCREASED 34 0.0014
710 HYPERSENSITIVITY 252 0.0014
711 UNDERDOSE 99 0.0014
712 PRESCRIBED UNDERDOSE 27 0.0014
713 CARDIOMYOPATHY 20 0.0014
714 DELUSION 21 0.0014
715 EJECTION FRACTION DECREASED 21 0.0013
716 EMOTIONAL DISTRESS 163 0.0013
717 NERVOUS SYSTEM DISORDER 42 0.0013
718 ERUCTATION 26 0.0013
719 PANCREATITIS 71 0.0013
720 AGGRESSION 67 0.0013
721 DERMATITIS 28 0.0013
722 CARDIAC DISORDER 125 0.0013
723 TASTE DISORDER 27 0.0013
724 CHROMATURIA 30 0.0013
725 HAEMOPTYSIS 37 0.0013
726 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 239 0.0013
727 VISUAL ACUITY REDUCED 44 0.0013
728 ACUTE MYOCARDIAL INFARCTION 39 0.0013
729 BODY TEMPERATURE DECREASED 13 0.0013
730 ALOPECIA 259 0.0013
731 GINGIVAL BLEEDING 18 0.0013
732 ABSCESS 21 0.0013
733 HYPERTHYROIDISM 19 0.0013
734 DRUG INTERACTION 208 0.0013
735 NEOPLASM 15 0.0013
736 PLATELET COUNT INCREASED 17 0.0013
737 GASTRIC HAEMORRHAGE 15 0.0013
738 PYREXIA 451 0.0013
739 MALAISE 570 0.0013
740 EMOTIONAL DISORDER 40 0.0013
741 BLOOD POTASSIUM INCREASED 21 0.0013
742 DRY SKIN 172 0.0013
743 ILEUS 16 0.0013
744 DRUG INTOLERANCE 124 0.0013
745 GOUT 23 0.0013
746 SPLENOMEGALY 15 0.0013
747 SKIN FISSURES 25 0.0013
748 DISCOMFORT 78 0.0013
749 INJECTION SITE MASS 47 0.0013
750 DECREASED APPETITE 295 0.0013
751 PELVIC PAIN 23 0.0013
752 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 90 0.0013
753 WHITE BLOOD CELL COUNT DECREASED 137 0.0013
754 HYPERTENSIVE CRISIS 14 0.0013
755 TOOTH LOSS 26 0.0013
756 THERAPEUTIC RESPONSE DECREASED 76 0.0013
757 PULMONARY OEDEMA 56 0.0012
758 INJECTION SITE REACTION 86 0.0012
759 GLAUCOMA 24 0.0012
760 INTENTIONAL DRUG MISUSE 26 0.0012
761 CONJUNCTIVITIS 23 0.0012
762 INTERSTITIAL LUNG DISEASE 60 0.0012
763 INJECTION SITE PAIN 379 0.0012
764 RESPIRATORY DISTRESS 34 0.0012
765 INTENTIONAL OVERDOSE 79 0.0012
766 CHOKING 24 0.0012
767 ORAL HERPES 24 0.0012
768 BLOOD GLUCOSE DECREASED 59 0.0012
769 SWELLING FACE 80 0.0012
770 INFLAMMATION 63 0.0012
771 OSTEONECROSIS 40 0.0012
772 URTICARIA 204 0.0012
773 INJECTION SITE ERYTHEMA 151 0.0012
774 INTENTIONAL PRODUCT MISUSE 106 0.0012
775 INJECTION SITE PRURITUS 81 0.0012
776 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
777 STOMATITIS 73 0.0012
778 PRODUCT ADHESION ISSUE 43 0.0012
779 EPISTAXIS 90 0.0012
780 RASH 524 0.0012
781 ERYTHEMA 247 0.0012
782 INJECTION SITE DISCOLOURATION 15 0.0012
783 PRODUCT QUALITY ISSUE 163 0.0012
784 RASH PRURITIC 65 0.0012
785 MYOCARDIAL INFARCTION 209 0.0012
786 BONE LOSS 18 0.0012
787 CARDIO-RESPIRATORY ARREST 50 0.0012
788 PRODUCT ADMINISTRATION ERROR 24 0.0012
789 DIABETES MELLITUS INADEQUATE CONTROL 21 0.0012
790 APPLICATION SITE ERYTHEMA 31 0.0012
791 IMPAIRED QUALITY OF LIFE 17 0.0012
792 DELIRIUM 41 0.0012
793 BACTERAEMIA 14 0.0012
794 TREATMENT NONCOMPLIANCE 64 0.0012
795 ASPARTATE AMINOTRANSFERASE INCREASED 62 0.0012
796 INJECTION SITE INDURATION 15 0.0012
797 CEREBROVASCULAR ACCIDENT 196 0.0012
798 MULTIPLE FRACTURES 19 0.0012
799 NO THERAPEUTIC RESPONSE 14 0.0011
800 PULMONARY FIBROSIS 22 0.0011
801 APPLICATION SITE PRURITUS 26 0.0011
802 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
803 PNEUMOTHORAX 18 0.0011
804 ANAEMIA 216 0.0011
805 DRUG EFFECT INCOMPLETE 41 0.0011
806 APPLICATION SITE IRRITATION 14 0.0011
807 GASTROINTESTINAL HAEMORRHAGE 94 0.0011
808 PERICARDIAL EFFUSION 26 0.0011
809 LUNG DISORDER 55 0.0011
810 MALIGNANT MELANOMA 15 0.0011
811 THERAPY INTERRUPTED 80 0.0011
812 GLOSSODYNIA 25 0.0011
813 RASH PAPULAR 25 0.0011
814 CARDIOGENIC SHOCK 16 0.0011
815 RESPIRATORY FAILURE 81 0.0011
816 ALANINE AMINOTRANSFERASE INCREASED 68 0.0011
817 FAECES DISCOLOURED 24 0.0011
818 PRODUCT AVAILABILITY ISSUE 25 0.0011
819 PRODUCT USE IN UNAPPROVED INDICATION 271 0.0011
820 FULL BLOOD COUNT DECREASED 22 0.0011
821 ADVERSE DRUG REACTION 98 0.0011
822 RASH ERYTHEMATOUS 52 0.0011
823 DIABETIC KETOACIDOSIS 26 0.0011
824 CYANOSIS 17 0.0011
825 BLOOD PRESSURE SYSTOLIC INCREASED 21 0.0011
826 ADRENAL INSUFFICIENCY 13 0.0011
827 LIVER FUNCTION TEST INCREASED 23 0.0011
828 INJECTION SITE SWELLING 82 0.0011
829 RESTLESSNESS 39 0.0011
830 HEPATIC CIRRHOSIS 20 0.0011
831 TARDIVE DYSKINESIA 30 0.0011
832 DRUG DOSE OMISSION 175 0.0011
833 DRUG DEPENDENCE 170 0.0011
834 CONTRAINDICATED PRODUCT ADMINISTERED 32 0.0011
835 ATRIAL FIBRILLATION 102 0.0010
836 THERAPY NON-RESPONDER 47 0.0010
837 HYPERGLYCAEMIA 38 0.0010
838 PARAESTHESIA ORAL 15 0.0010
839 ACCIDENTAL OVERDOSE 38 0.0010
840 DYSGEUSIA 77 0.0010
841 PRODUCT TASTE ABNORMAL 14 0.0010
842 DEAFNESS 27 0.0010
843 PRODUCT USE ISSUE 193 0.0010
844 INFUSION RELATED REACTION 68 0.0010
845 BASAL CELL CARCINOMA 16 0.0010
846 SWOLLEN TONGUE 32 0.0010
847 PSYCHOMOTOR HYPERACTIVITY 17 0.0010
848 PANCREATITIS ACUTE 23 0.0010
849 BONE DENSITY DECREASED 32 0.0010
850 LABORATORY TEST ABNORMAL 30 0.0010
851 HEPATITIS 26 0.0010
852 LIVER DISORDER 45 0.0010
853 EYE PRURITUS 34 0.0010
854 MOUTH ULCERATION 21 0.0010
855 SKIN EXFOLIATION 84 0.0010
856 HYPOAESTHESIA ORAL 15 0.0010
857 PRODUCT PHYSICAL ISSUE 20 0.0010
858 ANKYLOSING SPONDYLITIS 13 0.0010
859 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54 0.0010
860 RHABDOMYOLYSIS 41 0.0010
861 BRONCHOSPASM 14 0.0010
862 ADVERSE REACTION 13 0.0010
863 COLITIS 37 0.0010
864 BLOOD GLUCOSE ABNORMAL 18 0.0010
865 EYE IRRITATION 56 0.0010
866 LYMPHOMA 15 0.0010
867 PLEURAL EFFUSION 59 0.0010
868 OCULAR HYPERAEMIA 46 0.0010
869 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
870 HAEMATOCHEZIA 53 0.0010
871 INCORRECT DRUG ADMINISTRATION DURATION 27 0.0010
872 THERAPEUTIC PRODUCT EFFECT DECREASED 43 0.0010
873 DRUG INEFFECTIVE 1265 0.0010
874 SHOCK 22 0.0010
875 HOSPITALISATION 146 0.0009
876 HAEMOGLOBIN DECREASED 97 0.0009
877 INJECTION SITE HAEMORRHAGE 75 0.0009
878 HAEMORRHAGE INTRACRANIAL 14 0.0009
879 HAEMATURIA 32 0.0009
880 DERMATITIS ATOPIC 49 0.0009
881 NEEDLE ISSUE 27 0.0009
882 PRODUCT PREPARATION ERROR 19 0.0009
883 INJECTION SITE WARMTH 19 0.0009
884 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
885 ECZEMA 48 0.0009
886 DRUG DISPENSING ERROR 14 0.0009
887 ADVERSE EVENT 84 0.0009
888 TOXICITY TO VARIOUS AGENTS 153 0.0009
889 HYPOGLYCAEMIA 44 0.0009
890 HYPONATRAEMIA 51 0.0009
891 OVERDOSE 189 0.0009
892 BLOOD CREATININE INCREASED 57 0.0009
893 LIP SWELLING 29 0.0009
894 ARRHYTHMIA 41 0.0009
895 BLINDNESS 35 0.0009
896 BLOOD COUNT ABNORMAL 13 0.0009
897 STEVENS-JOHNSON SYNDROME 19 0.0009
898 PAIN OF SKIN 23 0.0009
899 NEOPLASM MALIGNANT 57 0.0009
900 EPILEPSY 26 0.0008
901 BLOOD GLUCOSE INCREASED 160 0.0008
902 HYPOCALCAEMIA 16 0.0008
903 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 60 0.0008
904 AGEUSIA 21 0.0008
905 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
906 DRUG PRESCRIBING ERROR 16 0.0008
907 ABDOMINAL PAIN LOWER 21 0.0008
908 FACE OEDEMA 14 0.0008
909 MEDICATION ERROR 46 0.0008
910 SEPTIC SHOCK 36 0.0008
911 LUNG NEOPLASM MALIGNANT 34 0.0008
912 DEMENTIA 23 0.0008
913 EXPOSURE VIA SKIN CONTACT 21 0.0008
914 OSTEONECROSIS OF JAW 20 0.0008
915 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
916 FRACTURE 15 0.0008
917 INTENTIONAL SELF-INJURY 16 0.0008
918 DRUG ERUPTION 14 0.0008
919 CARDIAC ARREST 65 0.0008
920 GENERAL PHYSICAL HEALTH DETERIORATION 91 0.0008
921 PRODUCT DISPENSING ERROR 17 0.0008
922 FREQUENT BOWEL MOVEMENTS 21 0.0008
923 HAEMORRHAGE 81 0.0008
924 RASH GENERALISED 20 0.0008
925 PRODUCT SUBSTITUTION ISSUE 43 0.0007
926 HYPOACUSIS 32 0.0007
927 AMENORRHOEA 13 0.0007
928 EXTRA DOSE ADMINISTERED 29 0.0007
929 GLYCOSYLATED HAEMOGLOBIN INCREASED 18 0.0007
930 OFF LABEL USE 621 0.0007
931 ILL-DEFINED DISORDER 43 0.0007
932 PLATELET COUNT DECREASED 75 0.0007
933 BLOOD BILIRUBIN INCREASED 19 0.0007
934 ERECTILE DYSFUNCTION 18 0.0007
935 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 142 0.0007
936 PREGNANCY 14 0.0007
937 DRUG ABUSE 58 0.0007
938 SKIN CANCER 15 0.0007
939 LIVER INJURY 17 0.0007
940 DEVICE ISSUE 62 0.0007
941 APPLICATION SITE PAIN 15 0.0007
942 INCORRECT DOSE ADMINISTERED 155 0.0007
943 VAGINAL HAEMORRHAGE 29 0.0007
944 HEPATIC FAILURE 20 0.0007
945 METABOLIC ACIDOSIS 21 0.0007
946 RENAL IMPAIRMENT 55 0.0007
947 DRUG ADMINISTRATION ERROR 20 0.0007
948 EXTRAPYRAMIDAL DISORDER 16 0.0006
949 EXPIRED PRODUCT ADMINISTERED 21 0.0006
950 SKIN BURNING SENSATION 45 0.0006
951 PSORIASIS 82 0.0006
952 HYPERKALAEMIA 22 0.0006
953 DEVICE MALFUNCTION 44 0.0006
954 DEVICE LEAKAGE 27 0.0006
955 ANAPHYLACTIC SHOCK 16 0.0006
956 PLASMA CELL MYELOMA 24 0.0006
957 BREAST CANCER FEMALE 16 0.0006
958 CARDIOVASCULAR DISORDER 15 0.0006
959 BREAST CANCER 55 0.0006
960 LEUKOPENIA 29 0.0006
961 CEREBRAL HAEMORRHAGE 20 0.0006
962 ACNE 41 0.0005
963 HEPATIC FUNCTION ABNORMAL 20 0.0005
964 MUCOSAL INFLAMMATION 14 0.0005
965 DEVICE DISLOCATION 23 0.0005
966 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
967 SKIN IRRITATION 22 0.0005
968 ACCIDENTAL EXPOSURE TO PRODUCT 49 0.0005
969 DISEASE PROGRESSION 56 0.0005
970 DEVICE BREAKAGE 19 0.0005
971 COLITIS ULCERATIVE 20 0.0004
972 NO ADVERSE EVENT 80 0.0004
973 DISEASE RECURRENCE 21 0.0004
974 CARDIAC FAILURE 35 0.0004
975 TREATMENT FAILURE 33 0.0004
976 THROMBOCYTOPENIA 40 0.0004
977 C-REACTIVE PROTEIN INCREASED 13 0.0004
978 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
979 ABORTION SPONTANEOUS 14 0.0003
980 DEPENDENCE 19 0.0003
981 NEUTROPHIL COUNT DECREASED 14 0.0003
982 MATERNAL EXPOSURE DURING PREGNANCY 30 0.0003
983 DEATH 282 0.0003
984 PANCYTOPENIA 18 0.0003
985 DEVICE DIFFICULT TO USE 21 0.0003
986 ANGIOEDEMA 14 0.0003
987 NEUTROPENIA 38 0.0003
988 EXPOSURE DURING PREGNANCY 15 0.0002
989 PRODUCT STORAGE ERROR 19 0.0002
990 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
991 PROSTATE CANCER 16 0.0002